Clinical Trial Update: A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension- [Phase 2]

View source ↗

Summary

ClinicalTrials.gov entry notes completion of a Phase 2 extension study evaluating the safety and efficacy of a new oral tacrolimus formulation (MR4) in bone mar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Tacrolimus MR4 (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Bone Marrow Transplantation, Graft Versus Host Disease | Phase 2 | Status: COMPLETED